[Pathogenesis of hemostasis disorders in malignant neoplasms].
The study was concerned with the effect of thrombin and Xa-factor on the procoagulative and fibrinolytic properties of cultured malignant cells (Hep-2). It was found that active coagulative factors of the blood promote the procoagulative and fibrinolytic potential of neoplasms involving the release of thromboplastic compounds and plasminogen activator into the environment.